|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
AmenorrheaFrom: George M. Grunert (ggrunert@houston.rr.com)Sun Mar 5 20:01:33 2000
There is evidence that DepoProvera causes decreased bone mineral density in adolescents and young women who are actively laying down bone (Cromer et al: J Pediatrics 1996 129:671 and Scholes et al: Obstet Gynecol 1999 93:233). Looking at women over 35, no significant difference was observed (Bahamondes et al: Fertil Steril 1999 71:849). Prior use apparently has no significant effect at menopause (Orr-Walker et al: Clin Endocrinol (Oxf) 1998 49:615). There appears to be a significant chemical and radiological effect in young women (under 35), but this may be of limited clinical importance since there is only a single report of a tibial stress fracture in a woman on DepoProvera (Harkins et al: J Reprod Med 1999 44:309). -----Original Message----- From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net]On Behalf Of Paul Prior MD Sent: Sunday, March 05, 2000 12:07 PM To: Multiple recipients of list OB-GYN-L Subject: Re: amenorrhea On Sun, 5 Mar 2000 10:20:58 -0600, "George M. Grunert, M.D." <grunert@ivfhouston.com> wrote:
>If they're on BCPs or DepoProvera, they're adequately protected from Would be interested in further comments regarding your statement that DepoProvera protects against osteoporosis.
|
|
Return to
|
Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Wed Dec 2 04:46:01 2009 |
The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.